Combination Immunotherapy for the Treatment of Chemotherapy-refractory Metastatic MSS CRC

Clinical trial NCT07281716 · RECRUITING

Trial details

NCT number: NCT07281716
Sponsor: Dan Feng
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Metastatic Microsatellite Stable Colorectal Carcinoma

Start date: 2025-12-01
Primary completion: 2028-12-15
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.